Sai Life Sciences opened lower at ₹1,795.00, compared with its previous close of ₹1,800.20. During today's session, the stock has traded between ₹1,738.00 and ₹1,815.00, with an average traded price of ₹1,769.63. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 2 years ago in Sai Life Sciences is now worth
₹ 22,852.00
Giving a profit of
₹ 12,852.00 (128.52%)
Note: Past profits do not guarantee future returns.
Rating by Refinitive from 5 Analysts
Today's Change
-52.80 (-2.93%)
Day High
₹1,815.00
Day Low
₹1,738.00
Day Open
₹1,795.00
Prev Close
₹1,800.20
Volume
15,02,057
Value Traded
₹265.81 Cr
1W Return
-4.87%
1M Return
25.77%
3M Return
20.52%
6M Return
60.18%
1Y Return
100.40%
Market Cap (₹ Cr.)
37,114
PE Ratio
101.70
PB Ratio
14.23
Dividend Yield
-
ROE
14.05%
ROCE
18.10%
Book Value (₹)
126.45
Face Value (₹)
1.00
EPS (TTM)
4.63
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-4.87%
6 Weeks
-
1 Month
25.77%
3 Months
20.52%
9 Months
89.80%
Sai Life Sciences Q2FY27 Results: Revenue up 23% YoY, capex plan intact
Consolidated revenue grew 23% YoY to ₹659 crore in Q2FY27, with CRO growing 28% and CDMO 20%. Net profit rose 17.3% YoY to ₹98 crore, while EBITDA margin held steady at 28%. Company commenced operations with first end-to-end integrated collaboration and converted another large pharma deal. Capex of ₹621 crore incurred in H1FY27; full-year plan of ₹1,100–1,300 crore remains intact. New Bidar capacity ready; additional 225 KL capacity delayed to early Q3FY28 without impacting FY28 revenue.
5 days agoSai Life Sciences latest guidance: 15-18% revenue CAGR, 28-30% margin
Sai Life Sciences has issued medium-term guidance for a revenue CAGR of 15-18%. The company targets EBITDA margins in the 28-30% range over the medium term. The guidance reflects a dual focus on topline growth and profitability sustainability.
6 days agoSai Life Sciences closes trading window from Oct 1 for Q2FY27 results
Trading window closed from October 1, 2026, for Q2FY27 results. Restriction applies to designated persons and immediate relatives. Window reopens 48 hours after financial results announcement. Board meeting date to be announced later.
1mo agoSai Life Sciences shareholders approve FY26 results, re-appoint CEO
Sai Life Sciences shareholders adopted FY26 audited financial statements at the 27th AGM held on September 17, 2026. The re-appointment of Managing Director Krishnam Raju Kanumuri passed with 99.02% support, despite 1.82% dissent from public institutions. Promoter shareholders voted 100% in favour on both resolutions, holding 73.29 million shares. Total votes polled exceeded 189 million, with remote e-voting conducted via KFin Technologies.
2mo agoSai Life Sciences to host investors at Jefferies forum on Sep 18
Sai Life Sciences hosts officials at Jefferies 5th India Forum. Meeting scheduled for September 18, 2026, in Gurugram. Sessions include group and one-on-one formats. Only publicly available information will be discussed.
2mo agoSai Life Sciences to host investor meeting at Morgan Stanley conference
Sai Life Sciences to host investors at Morgan Stanley conference on September 14, 2026. Meetings will be held in New York from 9:00 am to 6:00 pm EST. Discussions limited to publicly available information only. Schedule subject to change based on participant exigencies.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,872.40 | +0.26% | ₹4,49,251.48 | 40.80 | +6.56% | |
| ₹11,129.00 | +0.44% | ₹2,95,439.98 | 87.70 | +70.91% | |
| ₹4,643.10 | -1.03% | ₹1,76,608.60 | 85.00 | +21.17% | |
| ₹2,342.00 | +5.50% | ₹1,26,541.12 | 89.90 | +134.43% | |
| ₹1,204.00 | +1.01% | ₹1,20,099.46 | 27.60 | +27.48% | |
| ₹1,387.70 | +0.71% | ₹1,15,828.58 | 41.80 | +11.37% | |
| ₹1,388.80 | -0.41% | ₹1,12,195.38 | 39.50 | -9.35% | |
| ₹2,620.90 | -0.22% | ₹1,08,254.99 | 47.90 | +15.61% | |
| ₹1,794.50 | +0.03% | ₹1,03,251.56 | 25.80 | +46.79% | |
| ₹1,950.60 | -1.32% | ₹89,198.98 | 17.30 | -5.09% | |
| ₹2,611.20 | -0.82% | ₹73,694.51 | 51.10 | +37.75% | |
| ₹5,177.00 | +0.80% | ₹61,898.80 | 29.40 | -9.53% |
An investment of ₹10,000 made 2 years ago in Sai Life Sciences is now worth
₹ 22,852.00
Giving a profit of
₹ 12,852.00 (128.52%)
Note: Past profits do not guarantee future returns.